| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |